topSkip to main content

Menu, Secondary

Menu Trigger

Menu

New York's Leading Public Research Universities on the Forefront of Education and Innovation

New York’s leading public research universities are on the forefront of education and scientific innovation.


Only sixty-five years young, Stony Brook University is recognized as one of the nation’s top research universities, serving as a powerful engine for economic development, technological innovation and clinical care. SBU is not only transforming lives by revolutionizing cancer prognosis and advancing life-saving technologies for cardiac patients but also by offering a world-class education to students from all socio-economic backgrounds, providing them unmatched social and economic mobility.

The University at Buffalo was recognized as a research powerhouse back in 1989, when it became the first public university in New York invited to join the AAU, and its impact has only grown over the years. From developing new ways to treat memory loss in Alzheimer’s to pioneering minimally invasive surgical techniques, UB is making discoveries that lead to longer, healthier lives.

Learn more about the amazing work happening every day at New York's flagship public research universities:

Stony Brook Medicine is the first on Long Island to use FDA-approved vagus nerve stimulation (VNS) to help stroke survivors regain hand and arm function, even years after their stroke.
Stony Brook researchers uncovered how Eurasian shrews shrink and regrow their brains seasonally, revealing gene activity that may offer insights into human neurological and metabolic diseases.
Stony Brook University researchers are using 3D printing and recycled concrete to build sustainable shelters for Ukrainian refugees, offering a fast, low-carbon solution to a global housing crisis.
Stony Brook researchers developed PROMOTE, a prenatal screening tool that identifies pregnant women at risk for substance use, helping providers intervene early to protect maternal and infant health.
A University at Buffalo research program reveals that some of the so-called “gold standards” of MS monitoring are inadequate for patients with severe disease and that novel methods of assessing these people can be more effective.